Royalty Pharma plc logo

Royalty Pharma plc (RPRX)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
58. 18
-0.35
-0.598%
$
23.94B Market Cap
11.13 P/E Ratio
0.84% Div Yield
2.54M Volume
3.8 Eps
$ 58.53
Previous Close
Add Transaction
Day Range
58.12 59.44
Year Range
34.08 59.44
Want to track RPRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Royalty Pharma plc (RPRX) Statistics

Valuation metrics

Market Cap 23.94B
Enterprise value 33.39B
Trailing P/E (ttm) 23.61
Forward P/E -
PEG ratio -58.32
Price/Sales (ttm) 10.25
Price/Book (mrq) 3.65
Enterprise Value/Revenue 13.68
Enterprise Value/EBITDA 19.66

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.19M
Average volume (90 days) 3.36M

Price summary

52-Week low 34.08
52-Week high 59.44
Beta -
50-Day moving average 55.66
200-Day moving average 46.39

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.91
Trailing annual dividend yield 0.0156%
5-Year annual dividend yield -
Payout ratio 0.47
Dividend Date 10 Jun 2026
Ex-Dividend Date 15 May 2026
Last split factor -
Last split Date -

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.34%
Operating margin 0.68%

Operational effectiveness

Return on assets 0.04%
Return on equity 0.13%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 5.65
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.92
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.41
Total debt (mrq) -
Total Debt/Equity (mrq) 1.3
Current ratio (mrq) 2.66%
Book value per share (mrq) 23.01

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -